Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2928008 | Indian Heart Journal | 2012 | 5 Pages |
Abstract
Highly purified & concentrated omega-3 ethyl esters (90%) of EPA (460Â mg) & DHA (380Â mg) has clinically proven benefits in improving post MI outcomes (significant 15% risk reduction for all-cause mortality, 20% risk reduction for CVD and 45% risk reduction in SCD in GISSI-Prevenzione trial) and in reducing hypertriglyceridemia, and hence, represent an interesting option adding to the treatment armamentarium in the secondary prevention after MI based on its anti-arrhythmogenic effects and also in reducing hypertriglyceridemia.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
J.J. Dalal, R.R. Kasliwal, A.L. Dutta, J.P.S. Sawhney, S.S. Iyengar, S. Dani, N. Desai, I. Sathyamurthy, D. Rao, A. Menon, A. Dasbiswas, G.S. Wander, M. Chadha, M.S. Hiremath, D.G. Roy, V. Gupta, N. Shivakadaksham,